Cargando...
Combining activatable nanodelivery with immunotherapy in a murine breast cancer model
A successful chemotherapy-immunotherapy solid-tumor protocol should accomplish the following goals: debulk large tumors, release tumor antigen for cross-presentation and cross-priming, release cancer-suppressive cytokines and enhance anti-tumor immune cell populations. Thermally-activated drug deliv...
Gardado en:
| Publicado en: | J Control Release |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6660242/ https://ncbi.nlm.nih.gov/pubmed/30978432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2019.04.008 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|